Filing Flows › Comparisons › IDXX vs NEOG
Idexx Laboratories vs Neogen: IDXX and NEOG compared
Idexx Laboratories is the larger company: $1.2B of revenue in its latest quarter (Q3 2026) against $223M for Neogen (Q1 FY27). Idexx Laboratories is growing faster (+10% against +6% a year earlier). Idexx Laboratories is more profitable, with an operating margin of 33.1% against -0.8%.
Where the money goes: IDXX and NEOG
Idexx Laboratories (IDXX) · Q3 2026
Idexx Laboratories, Q3 2026: revenue $1.2B (+10% year over year), operating margin 33.1%, net earnings $317M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.
Neogen (NEOG) · Q1 FY27
Neogen, Q1 FY27: revenue $223M (+6% year over year), operating margin -0.8%, net loss $11.9M, operating cash flow $12.9M. The chart follows the revenue to costs, profit and cash.
| Idexx Laboratories (IDXX) | Neogen (NEOG) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q1 FY27 |
| Revenue | $1.2B | $223M |
| Revenue growth, Y/Y | +10% | +6% |
| Gross margin | 62.9% | — |
| Operating margin | 33.1% | -0.8% |
| Net earnings | $317M | −$11.9M |
| Net margin | 26.1% | -5.3% |
| Operating cash flow | $450M | $12.9M |
| Free cash flow | $421M | $4.7M |
| Market value | $53.5B | $2.6B |
| P/E | 45.6× | — |
| Analysts’ mean target | $717.17 | $14.00 |
Where the revenue comes from
Idexx Laboratories
- Product revenue: $723M (60%)
- Service revenue: $491M (40%)
Neogen
- Product: $196M (88%)
- Service: $26.8M (12%)
Questions
Which is bigger, Idexx Laboratories or Neogen?
Idexx Laboratories is the larger company: $1.2B of revenue in its latest quarter (Q3 2026) against $223M for Neogen (Q1 FY27).
Is Idexx Laboratories or Neogen growing faster?
Idexx Laboratories is growing faster (+10% against +6% a year earlier).
Which is more profitable, Idexx Laboratories or Neogen?
Idexx Laboratories is more profitable, with an operating margin of 33.1% against -0.8%.
More: Idexx Laboratories earnings · how Idexx Laboratories makes money · Neogen earnings · how Neogen makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 2, 2026; 10-Q filed Oct 7, 2026). Fiscal quarters can end on different dates. Not investment advice.